Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World

Table of Contents

EXECUTIVE SUMMARY

Section 1: BACKGROUND

• 1.1 Industry Structure
• 1.2 A Complex Industry
• 1.3 Major Wound Management Corporations
• 1.4 Historical Perspective and Technology Breakthroughs
• 1.5 World-Wide Regulatory and Reimbursement Environment
  • 1.5.1 Cost Effectiveness
  • 1.5.2 Clinical
  • 1.5.3 Regulatory
  • 1.5.4 Reimbursement
    • 1.5.4.1 U.S.A.
    • 1.5.4.2 European Union
    • 1.5.4.3 France
    • 1.5.4.4 Germany
    • 1.5.4.5 United Kingdom
    • 1.5.4.6 Italy
    • 1.5.4.7 Belgium
    • 1.5.4.8 Spain
    • 1.5.4.9 Scandinavia
• 1.6 Geographical Differences in Treatments of Wounds
• 1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
• 1.8 Wound Management Trends
  • 1.8.1 Surgical Wounds
  • 1.8.2 Traumatic Wounds
  • 1.8.3 Burns
  • 1.8.4 Chronic Wounds
• 1.9 Market Dynamics

Section 2: CLINICAL BACKGROUND AND CASELOAD

• 2.1 Background
  • 2.1.1 A few figures
  • 2.1.2 Overview of functions
  • 2.1.3 Skin Anatomy: a summary
• 2.2 Types of Wounds
  • 2.2.1 Classification By Severity
  • 2.2.2 Classification By Morphology
  • 2.2.3 Classification By Etiology
  • 2.2.4 Color Classification
• 2.3 Surgical Wounds
• 2.4 Traumatic Wounds
• 2.5 Burns
  • 2.5.1 Debridement
  • 2.5.2 Grafting
• 2.6 Pressure Ulcers
  • 2.6.1 Ulcer classification
  • 2.6.2 Hospital-acquired ulcers
  • 2.6.3 Management of pressure ulcers
• 2.7 Venous Ulcers
• 2.8 Arterial Ulcers
• 2.9 Diabetic Ulcers
  • 2.9.1 Prevalence
  • 2.9.2 Stages of Diabetic Ulcer
  • 2.9.3 Treatment
    • 2.9.3.1 Amputations
    • 2.9.3.2 Abnormal Scarring
  • 2.9.4 Acquired Immunodeficiency Syndrome
• 2.10 Wound Healing Physiology
  • 2.10.1 Inflammatory Phase
  • 2.10.2 Proliferative Phase
    • 2.10.2.1 Angiogenesis
  • 2.10.3 Maturation Phase
• 2.11 Factors Affecting Wound Healing
  • 2.11.1 Extrinsic Factors
  • 2.11.2 Mechanical Stress
  • 2.11.3 Debris
  • 2.11.4 Temperature
  • 2.11.5 Desiccation and Maceration
  • 2.11.6 Infection
  • 2.11.7 Chemical Stress
  • 2.11.8 Medication
  • 2.11.9 Other Extrinsic Factors
  • 2.11.10 Intrinsic Factors
  • 2.11.11 Health Status
  • 2.11.12 Age Factors
  • 2.11.13 Body Build
  • 2.11.14 Nutritional Status
• 2.12 Major Treatment Categories and Regimes
• 2.13 Incidence of Treatments, Growth Rates and Trends

Section 3: PRODUCTS, TECHNOLOGIES AND MARKETS

• 3.1 Background
• 3.2 Film Dressings
  • 3.2.1 Overview
  • 3.2.2 Product Examples
  • 3.2.3 Market and Competitive Activity
• 3.3 Hydrocolloids
  • 3.3.1 Overview
  • 3.3.2 Product Examples
  • 3.3.3 Market and Competitive Activity
• 3.4 Foam Dressings
  • 3.4.1 Overview
  • 3.4.2 Product Examples
  • 3.4.3 Market and Competitive Activity
• 3.5 Alginate Dressings
  • 3.5.1 Overview
  • 3.5.2 Product Examples
  • 3.5.3 Market and Competitive Activity
• 3.6 Hydrogels
  • 3.6.1 Overview
  • 3.6.2 Product Examples
  • 3.6.3 Market and Competitive Activity
• 3.7 Non Adherent Dressings
  • 3.7.1 Overview
  • 3.7.2 Product Examples
  • 3.7.3 Market and Competitive Activity
• 3.8 Antimicrobial Dressings
  • 3.8.1 Overview
  • 3.8.2 Product Examples
  • 3.8.3 Market and Competitive Activity
• 3.9 Tissue Engineered Products
  • 3.9.1 Overview
  • 3.9.2 Traditional skin grafts
  • 3.9.3 Skin replacements
  • 3.9.4 Product Examples
  • 3.9.5 Market and Competitive Analysis
• 3.10 Pharmacological Products
  • 3.10.1 Overview
  • 3.10.2 Product Examples
    • 3.10.2.1 Growth Factors
    • 3.10.2.2 Growth factors: background
    • 3.10.2.3 Classification
    • 3.10.2.4 Regranex
    • 3.10.2.5 Other Growth Factors
    • 3.10.2.6 Non-Growth Factor Modulators
  • 3.10.3 Market and Competitive Analysis
    • 3.10.3.1 Growth Factors
    • 3.10.3.2 Non-Growth Factor Stimulants
    • 3.10.3.3 Gene Therapy
• 3.11 Physical Treatments
  • 3.11.1 Negative Pressure Devices
  • 3.11.2 Positive Pressure Devices
  • 3.11.3 Mechanically-assisted Wound Closure
  • 3.11.4 Other Physical Wound Therapies
    • 3.11.4.1 Hydrotherapy
    • 3.11.4.2 Electrical Stimulation
    • 3.11.4.3 Electromagnetic Stimulation Devices
    • 3.11.4.4 Ultraviolet Therapy
    • 3.11.4.5 Hyperbaric Oxygen Therapy
    • 3.11.4.6 Ultrasound Devices
    • 3.11.4.7 Laser Devices
    • 3.11.4.8 Wound Imaging/Documentation
  • 3.11.5 Market and Competitive Analysis
    • 3.11.5.1 Pressure Relief Devices
    • 3.11.5.2 Hydrotherapy
    • 3.11.5.3 Electrical Stimulation
    • 3.11.5.4 Hyperbaric Oxygen Therapy

Section 4: COUNTRY MARKET ANALYSIS

• 4.1 Global Overview
• 4.2 Market Estimates
  • 4.2.1 Market potential
  • 4.2.2 Leading Wound Care Companies
  • 4.2.3 Leading National Markets
• 4.3 USA
  • 4.3.1 Market Opportunity
  • 4.3.2 Market for Advanced Wound Management Products
• 4.4 Japan
  • 4.4.1 Wound Care Market
  • 4.4.2 Market Opportunity
  • 4.4.3 Leading Companies
• 4.5 Germany
  • 4.5.1 Wound Care Market
  • 4.5.2 Leading Companies
• 4.6 France
  • 4.6.1 Wound Care Market
  • 4.6.2 Leading Companies
• 4.7 Italy
  • 4.7.1 Wound Care Market
  • 4.7.2 Leading Companies
• 4.8 United Kingdom
  • 4.8.1 Wound Care Market
  • 4.8.2 Leading Companies

Section 5: COMPANY PROFILES

• 5.1 Major Companies
• 5.2 Specialist Companies
  • 5.2.1 Antimicrobial Dressings
  • 5.2.2 Oxygen Therapy
  • 5.2.3 Skin Substitutes
  • 5.2.4 Hydrogels
  • 5.2.5 Growth Factors
  • 5.2.6 Odour Control
  • 5.2.7 Other Therapeutic Modalities
  • 5.2.8 Summary Profiles